Lyra therapeutics to present at upcoming virtual investor conferences

Watertown, mass., nov. 11, 2021 /prnewswire/ -- lyra therapeutics, inc. (nasdaq: lyra), a clinical-stage therapeutics company leveraging its proprietary xtreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ent) passages and other diseased tissues, today announced that maria palasis, ph.d.
LYRA Ratings Summary
LYRA Quant Ranking